abstract |
The present invention relates to compounds that inhibit protein tyrosine kinase activity. Specifically, the present invention relates to compounds that inhibit the protein tyrosine kinase activity of growth factor receptors, resulting in inhibition of receptor signaling, eg, inhibition of VEGF receptor signaling. The present invention also provides compounds, compositions, and methods for treating cell proliferative diseases and conditions, as well as ophthalmic diseases, disorders, and conditions. |